
Y-mAbs to Announce First Quarter 2023 Financial and Operating Results on May 8, 2023 28 April 2023
Apr 28, 2023PDF VersionNEW YORK, April 28, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics,... Read more

Apr 28, 2023PDF VersionNEW YORK, April 28, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics,... Read more

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more

Participate now in The Danish Biotech Salary Survey to find out. Finding the right balance between salary... Read more

NEW YORK, April 05, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more

Q4 2022 DANYELZA® record net product revenues of $16.4 million, driving YoY growth of 71% and 31%... Read more

Oslo Norway, March 23, 2023 Today LINK Medical has announced the integration of Pharm Assist into the... Read more

NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more

Finding the right balance between salary costs and the ability to attract and retain key talent is crucial... Read more

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more